Evaluation of serum 25-hydroxyvitamin D levels in calcific rheumatic mitral stenosis— A cross sectional study
Open Access
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Indian Heart Journal
- Vol. 70 (2) , 206-213
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- 1,25-Dihydroxyvitamin D 3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17AMolecular and Cellular Biology, 2011
- ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation, 2006
- ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: Executive SummaryCirculation, 2006
- Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone FormationCirculation, 2005
- Rheumatic Heart DiseaseThe American Journal of Pathology, 2004
- Identification of mononuclear cells and T cell subsets in rheumatic valvulitisClinical Immunology and Immunopathology, 1989
- Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation.Heart, 1988
- Comparison of the effects of 1,25‐dihydroxyvitamin D3 on T lymphocyte subpopulationsEuropean Journal of Immunology, 1987
- 1,25-Dihydroxyvitamin D 3 : a Novel Immunoregulatory HormoneScience, 1984
- 1,25-Dihydroxyvitamin D 3 Receptors in Human LeukocytesScience, 1983